a public good project by the
Synthesis
Company
of California

© 2026

Ken Mills | doi.page

0 works0 citations0 h-index

Ken Mills

Johns Hopkins University(US)Johns Hopkins Medicine(US)

Publications by Year

Research Areas

Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Histone Deacetylase Inhibitors Research

Most-Cited Works

→ Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group(2010)672 cited
→ Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia(2012)652 cited
→ External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial(2019)412 cited
→ Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure(2022)352 cited
→ Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936(2006)297 cited

→ Protein tyrosine phosphatase receptor type C (PTPRC or CD45)(2021)

225 cited

→ An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase(2008)224 cited

→ Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia(2005)200 cited

→ CD200 as a prognostic factor in acute myeloid leukaemia(2007)193 cited

→ Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome(2009)165 cited